CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in OMER — Omeros Corp
CIK 884546
SAN FRANCISCO, CA
Position in OMER
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,750,059
-$401,267 QoQ
Shares Held
604,633
+3.8% QoQ
Ownership
0.835%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. OMER ranks #128 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in OMER
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,750,059 | 604,633 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,151,326 | 582,512 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,191,553 | 593,222 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,269,214 | 553,467 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,439,037 | 479,679 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,813,110 | 463,882 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $4,698,196 | 475,526 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,925,588 | 485,035 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,894,318 | 466,581 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,740,073 | 504,369 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,534,198 | 469,174 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,433,626 | 490,968 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,535,469 | 466,079 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,563,706 | 336,281 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $706,044 | 312,409 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $970,952 | 308,239 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $772,381 | 280,866 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,745,920 | 456,892 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,805,846 | 436,368 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,929,534 | 429,988 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $6,321,112 | 425,951 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,415,925 | 416,625 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,764,943 | 403,425 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,013,386 | 396,972 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,063,356 | 343,978 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $4,252,168 | 318,038 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||